BioHealth News
Introducing the HJF-MDC Venture Fund: Fostering Medical Innovations for Military and Civilian Applications
Bethesda, Maryland - The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF) and MDC Studio, Inc (MDC) are proud to announce…
Read More
NIH OTT’s Tara Kirby Selected as IAM Market Maker
May 28, 2025 - The NIH Office of Technology Transfer Director, Dr. Tara Kirby, has been recognized by Intellectual Asset Management (IAM) as a Market…
Read More
Maryland Matters: Proposed Metro station development tied to growth of life sciences in Montgomery County
State and local leaders touted the promise of a proposed mixed-use development to be built over an existing North Bethesda Metro station as a…
Read More
FDA Grants RMAT Designation to AbelZeta’s C-CAR168 for Refractory Lupus
ROCKVILLE, Md., May 27, 2025 /PRNewswire/ -- AbelZeta Pharma, Inc. ("AbelZeta" or the "Company"), a global clinical-stage biopharmaceutical company focused on discovery and development of innovative…
Read More
Baltimore’s Rapafusyn Selected for Roche Accelerator to Tackle Challenging Drug Targets
Baltimore, MD, May 27, 2025 —Rapafusyn Pharmaceuticals Inc., a leader in non-degrading molecular glues, announced today the joining of the Roche Accelerator, Roche’s innovation…
Read More
CEL-SCI Announces Closing of Public Offering
VIENNA, Va.--(BUSINESS WIRE)--CEL-SCI Corporation (“CEL-SCI” or the “Company”) (NYSE American: CVM), a clinical stage cancer immunotherapy company, today announced the closing of its underwritten…
Read More
USM Chancellor Jay Perman: The Reasons for Undergraduate Research
University research has grabbed plenty of headlines over the past few months. Not for the breakthroughs that propel so much of American innovation. Not…
Read More
Senseonics Raises $77.8M Through Public Offering and Private Placement
GERMANTOWN, Md., May 21, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of…
Read More
ReGelTec Receives CE Mark for HYDRAFIL® System to Treat Chronic Low Back Pain
CE Mark approval for the HYDRAFIL System was granted based on a clinical study of 75 patients that showed that those treated with HYDRAFIL…
Read More
Quoin Pharmaceuticals Announces FDA Clearance to Initiate Second Pivotal Whole Body QRX003 Netherton Syndrome Clinical Study
ASHBURN, Va., May 22, 2025 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a clinical stage, specialty pharmaceutical company focused…
Read More
GeneDx Publishes Pioneering Vision for Applying AI to Genomics to Improve and Expedite Diagnosis of Genetic Disease at Scale
GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced the publication of a new article in…
Read More
HHS layoffs create ‘clear opportunity’ for local health, life sciences companies to add talent — BHI CEO Rich Bendis shares insights with the Washington Business Journal
By Sara Gilgore – Staff Reporter, Washington Business Journal - May 21, 2025 - Once the Department of Health and Human Services unveiled a…
Read More
June 10, 2025 Webinar: Turning Uncertainty to Opportunity: Mastering Government Funding in 2025
Navigating the Shifting Federal Funding Landscape Strategies, Insights, and AI-Driven Approaches for Winning Non-Dilutive Capital The federal funding landscape is undergoing a significant transformation.…
Read More
Ashburn’s Quoin Pharma’s QRX003 Granted Orphan Drug Status in Europe for Netherton Syndrome
ASHBURN, Va., May 20, 2025 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a late clinical stage, specialty pharmaceutical company…
Read More
REGENXBIO Announces Strategic Royalty Monetization Agreement for Up to $250 Million
ROCKVILLE, Md., May 19, 2025 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced the closure of a non-dilutive, limited recourse royalty bond agreement of up to $250 million with Healthcare…
Read More